Events

Please join us June 7-8, 2022, for ARM’s annual Congressional Fly-In as we come together to represent the cell and gene therapy sector to policymakers on Capitol Hill! We are pleased to return to in-person meetings, and to give our members the opportunity to share the sector’s promise and priorities with the Representatives and Senators who represent your districts and states. Your voices are critical to ensuring that policymakers understand the unique nature of these therapies and the policies needed to deliver them to patients.

The 2022 Planning Committee announces that the Call for Abstracts is open! One of the major barriers to manufacturing cells, tissues, and organs at commercial scale is producing components across the entire manufacturing supply chain to meet clinical demand. Further, minimizing resources to maximize output in a cost effective way is necessary to achieve scale.

Adam D. Gracz, PhD Assistant Professor Division of Digestive Diseases Emory University

Mark your calendar – Monday, June 13, 2022 – and join the Alliance for Regenerative Medicine and Precision ADVANCE for a private reception for cell and gene therapy industry executives during the BIO International Convention. Bring your business cards and enjoy extensive networking opportunities with the sector’s top decision makers including executives from leading companies located in the San Diego area!

The 2022 ISSCR Annual Meeting, co-sponsored by STEMCELL Technologies, gathers the world's leading scientists, clinicians, business leaders, ethicists, and educators from more than 65 countries. Together, we celebrate 20 years of excellence, advances, and contributions of stem cell research and regenerative medicine. Discovery, careers, advocacy, inspiration, new business, and relationships start here.

Katherine W. Rogers, PhD NIH NICHD Lead Investigator Unit on Developmental Signaling

The TERMIS-AM 2022 Conference will feature an outstanding scientific program bringing together national and international communities of scientists, clinicians, industry leaders, post-doctoral fellows, graduate students, entrepreneurs, and representatives of government funding agencies engaged in the fields of tissue engineering and regenerative medicine.

Dr. Richard McFarland will present during Workshop A, Examining iPSC Product Regulations to Incorporate Best Practice into Manufacturing Protocol to Cater to Requirements

The Cell, Gene, Immunotherapy event is for ground-breaking bioprocessing, manufacturing, and supply chain strategies.

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies.

The meeting will bring together international academic and commercial scientists with expertise in the preclinical, clinical, and regulatory phases to discuss the critical processes and strategies in the successful development of PSC-derived therapies.